论文信息 - Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination - 字舞流文

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination

B. Bošnjak | G. Sutter | B. Haagmans | R. Förster | C. Wendtner | W. Guggemos | M. Seilmaier | S. Becker | L. Sauerhering | I. Sandrock | Nisreen M. A. Okba | A. Volz | A. Kupke | K. Brosinski | E. Duell | A. Tscherne | G. Kalodimou | S. Jany | A. Werner | J. Schwarz | Leonard Limpinsel | Astrid Freudenstein | Nan Liangliang | Michael Klüver | Jörg Schmidt | Cornelius Rohde | Sandro Halwe | Michelle Gellhorn Sera | Lucie Sauerhering